Transcription of Genitourinary Pathogen Detection Panel Testing
{{id}} {{{paragraph}}}
Example: marketing
Genitourinary Pathogen Detection Panel Testing
UnitedHealthcare Commercial Medical Policy Genitourinary Pathogen nucleic acid Detection Panel Testing Policy Number: 2021T0608D. Effective Date: April 1, 2021 Instructions for Use Table of Contents Page Community Plan Policy Coverage Rationale .. 1 Genitourinary Pathogen nucleic acid Detection Definitions .. 1 Panel Testing Applicable Codes .. 2. Description of Services .. 2. Clinical Evidence .. 3. Food and Drug Administration .. 8. References .. 8. Policy History/Revision Information .. 10. Instructions for Use .. 10. Coverage Rationale The following are proven and medically necessary to evaluate symptomatic women for Vaginitis: Direct and amplified DNA probe Testing for Trichomoniasis vaginalis Direct probe Testing for Candida sp Due to insufficient evidence of efficacy, the following are unproven and not medically necessary: Amplified DNA probe Testing for
Genitourinary Pathogen Nucleic Acid Detection Panel Testing Page 1 of 11 ... Gardnerella vaginalis (as a marker for BV), and T. vaginalis. Clinical Evidence : Common Causes of Vaginitis The most common causes of vaginitis include trichomoniasis, bacterial vaginosis (BV), and vulvovaginal candidiasis (VVC).
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: